ABT vs FRMEP · P/E 25, rev $44.33B vs P/E 6.6, $2.42B cap
Abbott Laboratories (ABT) versus First Merchants Corporation Depository Shares (FRMEP) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
First Merchants Corporation Depository Shares (FRMEP) is a banks - regional company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
FRMEP does not have a complete income-statement cache yet.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. FRMEP currently screens at market cap $2.42B and trailing P/E 6.6.
Not investment advice. Open the ABT and FRMEP stock pages for the full models.
Not investment advice.